Catalent
Enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $16.5b Valuation: $16.5b 3.8x EV/Revenue 39.0x EV/EBITDA | Acquisition | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 29 % | 21 % | (11 %) | 2 % | 6 % | 8 % | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 16 % | 15 % | 2 % | 10 % | 18 % | 20 % | 20 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 15 % | 11 % | (5 %) | (24 %) | (4 %) | 1 % | 1 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Catalent is a global leader in enabling pharmaceutical, biotechnology, and consumer health partners to optimize their product development, launch, and full lifecycle supply. The company operates in the healthcare market, serving clients ranging from large pharmaceutical companies to emerging biotech firms. Catalent's business model focuses on providing comprehensive solutions that enhance the efficiency and effectiveness of drug development and delivery. This includes services such as drug formulation, manufacturing, clinical supply, and commercial packaging. Catalent generates revenue through long-term contracts and partnerships with its clients, offering tailored solutions that meet the specific needs of each project. The company is committed to high business standards, corporate responsibility, and sustainability, actively working to reduce greenhouse gas emissions, waste, and water use. Catalent also invests in its communities by promoting STEM education and supporting diverse and inclusive workplaces.
Keywords: pharma, biotech, consumer health, drug development, manufacturing, clinical supply, commercial packaging, sustainability, STEM, diversity.
Tech stack
Investments by Catalent
Edit
